Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2004 1
2005 1
2011 4
2012 5
2013 2
2014 5
2015 6
2016 2
2017 3
2018 4
2019 2
2020 6
2021 4
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: Clinical Trial. Clear all
Page 1
Access-site hematoma in distal and conventional transradial access: a randomized trial.
Lucreziotti S, Persampieri S, Gentile D, Barbieri L, Salerno-Uriarte D, Valli F, Sabatelli L, Panzacchi G, Centola M, Carugo S. Lucreziotti S, et al. Minerva Cardiol Angiol. 2022 Apr;70(2):129-137. doi: 10.23736/S2724-5683.21.05483-9. Epub 2021 Mar 11. Minerva Cardiol Angiol. 2022. PMID: 33703855 Clinical Trial.
BACKGROUND: Distal transradial access (dTRA) has been recently proposed as an innovative access for coronary procedures and a valuable alternative to conventional transradial access (cTRA). ...The primary endpoint was an early discharge after transradial sten …
BACKGROUND: Distal transradial access (dTRA) has been recently proposed as an innovative access for coronary procedures and a …
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
Li Y, Liang Z, Qin L, Wang M, Wang X, Zhang H, Liu Y, Li Y, Jia Z, Liu L, Zhang H, Luo J, Dong S, Guo J, Zhu H, Li S, Zheng H, Liu L, Wu Y, Zhong Y, Qiu M, Han Y, Stone GW. Li Y, et al. Lancet. 2022 Nov 26;400(10366):1847-1857. doi: 10.1016/S0140-6736(22)01999-7. Epub 2022 Nov 6. Lancet. 2022. PMID: 36351459 Clinical Trial.
There were no significant differences in the 30-day rates of reinfarction, stroke, or ischaemia-driven target vessel revascularisation between the groups. ...INTERPRETATION: In patients with STEMI undergoing primary PCI predominantly with radial artery access
There were no significant differences in the 30-day rates of reinfarction, stroke, or ischaemia-driven target vessel revascularisatio …
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.
Hemetsberger R, Richardt G, Lahu S, Valina C, Menichelli M, Abdelghani M, Wöhrle J, Toelg R, Witzenbichler B, Mankerious N, Liebetrau C, Bernlochner I, Hamm CW, Allali A, Joner M, Fusaro M, Xhepa E, Hapfelmeier A, Kufner S, Sager HB, Schüpke S, Laugwitz KL, Schunkert H, Neumann FJ, Kastrati A, Cassese S. Hemetsberger R, et al. Cardiovasc Revasc Med. 2022 Aug;41:122-128. doi: 10.1016/j.carrev.2021.12.029. Epub 2022 Jan 3. Cardiovasc Revasc Med. 2022. PMID: 35045943 Clinical Trial.
METHODS: This post-hoc analysis included ACS patients undergoing invasive treatment via radial or femoral access and randomized to either ticagrelor or prasugrel in the ISAR-REACT 5 trial. ...RESULTS: Out of 4018 patients, 3984 underwent invasive treatment via ra
METHODS: This post-hoc analysis included ACS patients undergoing invasive treatment via radial or femoral access and randomize …
Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): a randomised controlled trial.
Nguyen P, Makris A, Hennessy A, Jayanti S, Wang A, Park K, Chen V, Nguyen T, Lo S, Xuan W, Leung M, Juergens C. Nguyen P, et al. EuroIntervention. 2019 Aug 9;15(6):e522-e530. doi: 10.4244/EIJ-D-19-00336. EuroIntervention. 2019. PMID: 31113763 Free article. Clinical Trial.
AIMS: This study aimed to compare outcomes in unselected patients undergoing cardiac catheterisation via transradial versus transfemoral access and standard versus ultrasound-guided arterial access. METHODS AND RESULTS: This was a prospective, randomised (radial
AIMS: This study aimed to compare outcomes in unselected patients undergoing cardiac catheterisation via transradial versus transfemoral …
Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention.
Jolly SS, Cairns J, Yusuf S, Niemela K, Steg PG, Worthley M, Ferrari E, Cantor WJ, Fung A, Valettas N, Rokoss M, Olivecrona GK, Widimsky P, Cheema AN, Gao P, Mehta SR; RIVAL Investigators. Jolly SS, et al. J Am Coll Cardiol. 2014 Mar 18;63(10):954-63. doi: 10.1016/j.jacc.2013.10.052. Epub 2013 Nov 21. J Am Coll Cardiol. 2014. PMID: 24269362 Free article. Clinical Trial.
OBJECTIVES: The study sought to evaluate the relationship between procedural volume and outcomes with radial and femoral approach. BACKGROUND: RIVAL (RadIal Vs. femorAL) was a randomized trial of radial versus femoral access for coronary angiography/in …
OBJECTIVES: The study sought to evaluate the relationship between procedural volume and outcomes with radial and femoral approach. BA …
Safety and Efficacy of Femoral Access vs Radial Access in ST-Segment Elevation Myocardial Infarction: The SAFARI-STEMI Randomized Clinical Trial.
Le May M, Wells G, So D, Chong AY, Dick A, Froeschl M, Glover C, Hibbert B, Marquis JF, Blondeau M, Osborne C, MacDougall A, Kass M, Paddock V, Quraishi A, Labinaz M. Le May M, et al. JAMA Cardiol. 2020 Feb 1;5(2):126-134. doi: 10.1001/jamacardio.2019.4852. JAMA Cardiol. 2020. PMID: 31895439 Free PMC article. Clinical Trial.
RESULTS: Among the 2292 patients enrolled, the mean (SD) age of the patients randomized to radial access was 61.6 (12.3) years and to femoral access was 62.0 (12.1) years, with 883 male patients in the radial access and 901 male patients in the …
RESULTS: Among the 2292 patients enrolled, the mean (SD) age of the patients randomized to radial access was 61.6 (12.3) years …
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.
Gao C, Buszman P, Buszman P, Chichareon P, Modolo R, Garg S, Takahashi K, Kawashima H, Wang R, Chang CC, Kogame N, Tomaniak M, Ono M, Hara H, Slagboom T, Aminian A, Naber CK, Carrie D, Hamm C, Steg PG, Onuma Y, Geuns RV, Serruys PW, Zurakowski A. Gao C, et al. Can J Cardiol. 2021 Jan;37(1):122-130. doi: 10.1016/j.cjca.2020.01.029. Epub 2020 Feb 21. Can J Cardiol. 2021. PMID: 32450057 Free article. Clinical Trial.
BACKGROUND: Radial artery access has been shown to reduce mortality and bleeding events, especially in patients with acute coronary syndromes. ...Radial access was associated with a significantly lower rate of the secondary safety end point, Bleeding A …
BACKGROUND: Radial artery access has been shown to reduce mortality and bleeding events, especially in patients with acute cor …
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van 't Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P; MATRIX Investigators. Valgimigli M, et al. Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25. Lancet. 2018. PMID: 30153988 Clinical Trial.
BACKGROUND: The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versu …
BACKGROUND: The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) prog …
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.
Guedeney P, Thiele H, Kerneis M, Barthélémy O, Baumann S, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Piek JJ, Landmesser U, Hauguel-Moreau M, Zeitouni M, Silvain J, Lattuca B, Windecker S, Collet JP, Desch S, Zeymer U, Montalescot G, Akin I; CULPRIT-SHOCK Investigators. Guedeney P, et al. Am Heart J. 2020 Jul;225:60-68. doi: 10.1016/j.ahj.2020.04.014. Epub 2020 Apr 30. Am Heart J. 2020. PMID: 32497906 Clinical Trial.
BACKGROUND: The use and impact of transradial artery access (TRA) compared to transfemoral artery access (TFA) in patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (MI) complicated by cardiogenic shock (CS) remain unclear. …
BACKGROUND: The use and impact of transradial artery access (TRA) compared to transfemoral artery access (TFA) in patients und …
Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial.
Cantor WJ, Mehta SR, Yuan F, Džavík V, Worthley M, Niemelä K, Valentin V, Fung A, Cheema AN, Widimsky P, Natarajan M, Jedrzejowski B, Jolly SS. Cantor WJ, et al. Am Heart J. 2015 Nov;170(5):880-6. doi: 10.1016/j.ahj.2015.08.011. Epub 2015 Aug 16. Am Heart J. 2015. PMID: 26542495 Clinical Trial.
BACKGROUND: Radial access for percutaneous coronary intervention is associated with lower rates of access site complications and bleeding. However, elderly patients have more complex vascular anatomy and radial access may be more challenging in …
BACKGROUND: Radial access for percutaneous coronary intervention is associated with lower rates of access site complica …
45 results